data_2run_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2run _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.5 -0.24 . . . . 74.219999999999999 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.230000000000004 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 73.430000000000007 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.430000000000007 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.140000000000001 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.299999999999997 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.482 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 74.120000000000005 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 75.519999999999996 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.943 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.329999999999998 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.111 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.329999999999998 110.938 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.249 . . . . 74.109999999999999 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 72.109999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.329999999999998 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.867 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.049999999999997 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.152 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.219999999999999 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.010000000000005 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.519999999999996 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.523 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 72.209999999999994 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.148 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.926 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.503 -0.239 . . . . 70.140000000000001 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 74.019999999999996 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.85 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.239999999999995 111.13 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.239999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.310000000000002 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 73.540000000000006 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 111.128 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 110.922 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.49 -0.244 . . . . 55.109999999999999 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 72.310000000000002 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 74.209999999999994 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.868 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 73.019999999999996 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 111.137 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.540000000000006 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.099999999999994 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.140000000000001 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.010000000000005 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.108 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.219999999999999 110.912 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.531 -0.228 . . . . 60.219999999999999 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 74.109999999999999 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.834 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 64.299999999999997 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 111.173 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.340000000000003 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 75.109999999999999 111.096 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.914 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.501 -0.24 . . . . 62.140000000000001 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.430000000000007 110.881 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 73.120000000000005 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.519999999999996 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 111.131 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.954 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.491 -0.243 . . . . 73.530000000000001 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 75.230000000000004 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.030000000000001 110.879 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.154 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 74.209999999999994 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 74.340000000000003 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.129999999999995 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.349999999999994 111.121 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.939 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.491 -0.244 . . . . 73.439999999999998 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 72.230000000000004 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.349999999999994 111.147 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.120000000000005 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 73.540000000000006 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.0 111.109 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.849 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.443 -0.263 . . . . 44.119999999999997 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 74.219999999999999 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 70.340000000000003 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 75.400000000000006 111.091 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 75.540000000000006 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.140000000000001 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 75.129999999999995 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.938 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.516 -0.234 . . . . 64.340000000000003 112.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 75.299999999999997 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 74.120000000000005 110.924 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 65.519999999999996 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 111.121 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 72.140000000000001 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.239999999999995 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 72.230000000000004 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.517 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.239999999999995 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.149 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.982 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.518 -0.233 . . . . 61.140000000000001 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 70.400000000000006 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.439999999999998 110.866 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.439999999999998 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.519999999999996 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 75.239999999999995 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.239999999999995 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.132 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.549999999999997 110.913 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 73.430000000000007 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 65.019999999999996 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.329999999999998 110.913 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 72.340000000000003 111.108 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 73.319999999999993 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 74.140000000000001 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 71.510000000000005 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.109999999999999 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 75.230000000000004 111.182 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 110.92 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.484 -0.247 . . . . 73.329999999999998 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.409999999999997 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.019999999999996 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.120000000000005 110.88 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 71.230000000000004 111.139 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 70.049999999999997 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.510000000000005 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 72.040000000000006 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.319999999999993 111.151 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 110.936 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.513 -0.235 . . . . 73.519999999999996 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.230000000000004 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.882 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 75.510000000000005 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 111.145 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 73.549999999999997 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 74.519999999999996 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.519999999999996 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.319999999999993 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.102 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.506 -0.237 . . . . 73.420000000000002 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 70.319999999999993 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 75.010000000000005 110.879 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 111.143 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 75.019999999999996 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.409999999999997 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.319999999999993 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.139 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 110.881 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 64.049999999999997 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 73.219999999999999 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.485 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 65.150000000000006 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 64.329999999999998 110.846 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 75.25 111.144 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 75.510000000000005 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.519 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.510000000000005 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 63.520000000000003 111.096 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 72.400000000000006 110.906 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.49 -0.244 . . . . 50.32 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.450000000000003 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.140000000000001 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.874 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.030000000000001 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 111.152 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.129999999999995 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 74.329999999999998 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 72.540000000000006 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 72.049999999999997 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 73.549999999999997 111.146 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 72.299999999999997 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 74.439999999999998 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.510000000000005 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.852 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.239999999999995 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 74.420000000000002 111.129 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 111.161 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.219999999999999 110.919 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.504 -0.238 . . . . 61.340000000000003 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 75.430000000000007 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.487 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.040000000000006 111.085 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.200000000000003 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.140000000000001 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 72.319999999999993 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 111.112 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.895 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.467 -0.253 . . . . 63.219999999999999 112.467 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 74.340000000000003 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.861 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.132 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.420000000000002 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 74.120000000000005 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.549999999999997 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.958 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.856 0.36 . . . . 75.310000000000002 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.29 18.26 10.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 74.219999999999999 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.230000000000004 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 73.430000000000007 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.402 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.430000000000007 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.140000000000001 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.299999999999997 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 74.120000000000005 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 75.519999999999996 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.943 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.329999999999998 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.111 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -89.93 -54.12 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 71.329999999999998 110.938 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -130.18 116.78 18.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 73.409999999999997 110.91 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.87 -10.25 44.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 52.439999999999998 112.462 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 41.8 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.885 -179.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.831 0.348 . . . . 74.400000000000006 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.19 18.17 11.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 74.109999999999999 112.479 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 72.109999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.329999999999998 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.867 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.049999999999997 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.152 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.219999999999999 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.010000000000005 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 74.519999999999996 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.523 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 72.209999999999994 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.5 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 111.148 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -88.88 -54.61 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.26 119.33 24.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 72.439999999999998 110.908 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.08 57.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 71.040000000000006 112.449 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 73.420000000000002 110.91 -179.882 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.797 0.332 . . . . 74.299999999999997 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.12 18.27 54.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 70.140000000000001 112.503 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 74.019999999999996 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.494 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.85 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.239999999999995 111.13 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.239999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.310000000000002 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 73.540000000000006 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 111.128 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -88.98 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 110.922 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.26 119.32 24.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.899 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.2 57.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 55.020000000000003 112.457 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.7 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 75.340000000000003 110.884 -179.843 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.874 0.369 . . . . 74.420000000000002 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.28 16.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 55.109999999999999 112.49 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 72.310000000000002 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 74.209999999999994 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.868 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 73.019999999999996 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 74.319999999999993 111.137 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.540000000000006 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.099999999999994 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.140000000000001 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.010000000000005 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 111.108 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -89.01 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.219999999999999 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.31 119.31 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 75.310000000000002 110.934 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.0 57.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 72.319999999999993 112.485 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 73.129999999999995 110.857 -179.869 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.845 0.355 . . . . 71.109999999999999 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.36 18.24 19.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 60.219999999999999 112.531 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 74.109999999999999 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.834 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 64.299999999999997 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 111.173 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.340000000000003 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 75.109999999999999 111.096 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -88.96 -54.55 4.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.914 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.26 119.34 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 72.25 110.937 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -7.08 57.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 72.329999999999998 112.499 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 73.319999999999993 110.908 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.842 0.353 . . . . 72.319999999999993 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.1 18.24 29.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.501 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 75.340000000000003 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.481 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.430000000000007 110.881 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.093 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 73.120000000000005 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.519999999999996 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 111.131 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -88.93 -54.56 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 75.409999999999997 110.954 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 tp -128.25 119.33 24.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 110.944 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -6.97 57.36 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 73.319999999999993 112.483 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.3 p90 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 72.040000000000006 110.884 -179.855 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 18.24 33.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 73.530000000000001 112.491 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 75.230000000000004 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.482 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.030000000000001 110.879 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.154 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 74.209999999999994 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 74.340000000000003 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.129999999999995 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.349999999999994 111.121 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -88.97 -54.54 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 74.519999999999996 110.939 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -128.28 119.32 24.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 64.310000000000002 110.878 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.26 57.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 73.409999999999997 112.484 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 71.310000000000002 110.851 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.872 0.368 . . . . 72.409999999999997 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.12 17.99 9.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 73.439999999999998 112.491 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 72.230000000000004 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.874 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 65.349999999999994 111.147 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 74.109999999999999 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.120000000000005 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 73.540000000000006 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 72.0 111.109 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -89.1 -54.53 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.849 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.29 119.3 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 73.209999999999994 110.944 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.11 57.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 75.319999999999993 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 74.420000000000002 110.91 -179.871 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.352 . . . . 71.099999999999994 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.74 17.78 72.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 44.119999999999997 112.443 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 74.219999999999999 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.92 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 70.340000000000003 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 75.400000000000006 111.091 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.349999999999994 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.521 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 75.540000000000006 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.140000000000001 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 75.129999999999995 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -89.04 -54.53 4.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.938 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.29 119.26 24.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.9 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.99 -7.18 57.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 54.329999999999998 112.511 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 62.409999999999997 110.867 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.858 0.361 . . . . 70.030000000000001 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.15 59.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 64.340000000000003 112.516 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 75.299999999999997 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 74.120000000000005 110.924 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 65.519999999999996 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 73.310000000000002 111.121 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 72.140000000000001 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.239999999999995 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 72.230000000000004 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.517 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.239999999999995 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.149 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -88.95 -54.5 4.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.982 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.34 119.3 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.877 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.1 57.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 73.519999999999996 112.448 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 73.120000000000005 110.873 -179.841 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.56 18.17 21.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 61.140000000000001 112.518 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 70.400000000000006 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.49 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.439999999999998 110.866 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.439999999999998 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 74.519999999999996 111.12 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.099999999999994 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 75.239999999999995 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.52 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.239999999999995 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 74.409999999999997 111.132 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -89.03 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.549999999999997 110.913 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 tp -128.27 119.3 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.439999999999998 110.888 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.512 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 110.872 -179.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.899 0.38 . . . . 74.120000000000005 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.21 56.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 73.430000000000007 112.526 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 65.019999999999996 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.329999999999998 110.913 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 75.420000000000002 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 72.340000000000003 111.108 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 73.319999999999993 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 74.140000000000001 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 71.510000000000005 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.518 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.109999999999999 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 75.230000000000004 111.182 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -89.05 -54.55 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 74.340000000000003 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.27 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 72.239999999999995 110.938 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.08 57.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 50.329999999999998 112.491 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 74.340000000000003 110.889 -179.875 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.855 0.36 . . . . 64.420000000000002 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.91 18.23 79.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 73.329999999999998 112.484 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.409999999999997 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.491 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.019999999999996 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 74.120000000000005 110.88 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 71.230000000000004 111.139 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 70.049999999999997 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.510000000000005 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 72.040000000000006 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.515 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 72.439999999999998 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 72.430000000000007 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.319999999999993 111.151 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -89.02 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 75.230000000000004 110.936 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.26 119.33 24.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 71.040000000000006 110.92 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 73.400000000000006 112.478 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 74.140000000000001 110.855 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.877 0.37 . . . . 75.5 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.76 18.2 38.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 73.519999999999996 112.513 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.230000000000004 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.489 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.882 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 75.519999999999996 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 75.510000000000005 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 111.145 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 74.040000000000006 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 73.549999999999997 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 74.519999999999996 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.519999999999996 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.319999999999993 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.230000000000004 111.102 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -88.99 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.3 119.24 24.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.099999999999994 110.877 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.97 -7.19 57.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 64.219999999999999 112.486 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 74.299999999999997 110.883 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.855 0.359 . . . . 74.129999999999995 110.916 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.63 18.19 16.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 73.420000000000002 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.486 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 70.319999999999993 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 75.010000000000005 110.879 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.530000000000001 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 111.143 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 75.019999999999996 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.409999999999997 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.319999999999993 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.340000000000003 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.139 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.0 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 110.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.29 119.28 24.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 74.150000000000006 110.92 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.91 -7.13 57.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 74.109999999999999 112.464 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.774 0.321 . . . . 73.510000000000005 110.841 -179.834 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 65.010000000000005 110.914 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.24 18.3 26.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 64.049999999999997 112.499 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 73.219999999999999 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.485 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 65.150000000000006 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 64.329999999999998 110.846 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 75.25 111.144 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 75.510000000000005 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.519 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.510000000000005 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 63.520000000000003 111.096 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -89.03 -54.54 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 72.400000000000006 110.906 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.26 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.929 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.99 57.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 71.549999999999997 112.483 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 75.430000000000007 110.844 -179.863 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.855 0.36 . . . . 72.010000000000005 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.28 77.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 50.32 112.49 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.450000000000003 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.140000000000001 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.874 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 75.129999999999995 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.030000000000001 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 73.040000000000006 111.152 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.129999999999995 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 74.329999999999998 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.522 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 72.540000000000006 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 72.049999999999997 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 73.549999999999997 111.146 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -88.98 -54.59 4.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.4 tp -128.25 119.29 24.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.040000000000006 110.944 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.9 -7.1 57.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 72.409999999999997 112.483 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 74.150000000000006 110.848 -179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.856 0.36 . . . . 73.549999999999997 110.899 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.03 18.22 70.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.738 . . . . 72.299999999999997 112.501 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 74.439999999999998 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.484 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.510000000000005 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.852 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.239999999999995 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 74.420000000000002 111.129 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 74.439999999999998 111.161 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -88.98 -54.56 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.219999999999999 110.919 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.28 119.31 24.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 110.926 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.1 57.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.739 . . . . 74.299999999999997 112.519 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 72.530000000000001 110.924 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.881 0.372 . . . . 75.129999999999995 110.919 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.11 18.21 56.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 61.340000000000003 112.504 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 75.430000000000007 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.487 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 73.219999999999999 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 73.519999999999996 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.040000000000006 111.085 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 72.540000000000006 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.523 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.200000000000003 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.140000000000001 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 72.319999999999993 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 111.112 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -89.02 -54.56 4.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.28 119.34 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 73.129999999999995 110.95 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.83 -7.08 57.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 73.439999999999998 112.499 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 73.019999999999996 110.909 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.863 0.363 . . . . 73.299999999999997 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.43 18.21 13.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 63.219999999999999 112.467 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 74.340000000000003 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TYR . . . . . 0.488 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 75.099999999999994 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.861 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.132 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.420000000000002 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 10' ' ' TRP . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 74.120000000000005 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.549999999999997 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 72.450000000000003 111.155 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -88.92 -54.57 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.958 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.4 tp -128.24 119.35 25.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.040000000000006 110.9 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.09 57.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 71.340000000000003 112.496 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 73.400000000000006 110.872 -179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.5 -0.24 . . . . 44.32 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.23 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 64.12 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.43 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.14 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.24 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.3 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 52.34 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 64.3 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 74.05 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.0 110.943 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.33 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.111 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.938 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.249 . . . . 60.22 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 61.15 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.867 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.13 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.05 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 71.21 111.152 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.01 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 63.41 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 70.45 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.33 111.148 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 63.51 110.926 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.503 -0.239 . . . . 70.14 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 71.43 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.85 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.14 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 54.33 111.13 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.31 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 53.33 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 64.25 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 62.45 110.922 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.49 -0.244 . . . . 34.1 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 65.5 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 71.32 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.43 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 53.22 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 53.23 111.137 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.54 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.1 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.14 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.01 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 54.13 111.108 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.22 110.912 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.531 -0.228 . . . . 55.5 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 72.43 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' A' ' 8' ' ' ILE . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.11 110.834 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 63.13 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.55 111.173 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.41 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.3 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.2 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 61.41 111.096 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.914 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.501 -0.24 . . . . 62.14 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 73.52 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 62.15 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.43 110.881 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.21 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.093 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 72.44 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.31 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.52 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.2 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.954 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.491 -0.243 . . . . 73.53 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 74.14 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 8' ' ' ILE . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.03 110.879 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.4 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.154 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 62.24 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 70.04 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.41 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 65.45 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.13 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.03 111.121 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.939 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.491 -0.244 . . . . 73.44 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 71.03 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 62.35 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.874 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 54.22 111.147 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 71.3 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 72.41 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.12 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 71.04 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 53.55 111.109 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.849 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.443 -0.263 . . . . 44.12 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 65.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.02 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.43 110.92 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 44.04 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.02 111.091 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.03 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 74.44 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.14 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 72.12 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.2 110.938 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.516 -0.234 . . . . 64.15 112.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 65.3 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 40.21 110.924 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.23 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 64.54 111.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 61.34 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.24 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 54.14 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 61.4 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.23 111.149 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.44 110.982 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.518 -0.233 . . . . 55.12 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 55.22 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.44 110.866 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.3 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.4 111.12 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.01 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 74.13 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.54 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.24 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 71.42 111.132 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.913 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 61.01 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 62.1 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.33 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 61.21 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 70.54 111.108 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.54 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 72.34 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 64.11 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.11 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.11 111.182 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 71.44 110.92 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.484 -0.247 . . . . 73.33 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.41 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.02 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 62.14 110.88 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 55.51 111.139 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 65.45 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.51 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 71.34 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 63.31 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 32.11 111.151 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.936 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.513 -0.235 . . . . 73.43 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.23 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.681 ' HA ' HG22 ' A' ' 8' ' ' ILE . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.882 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 63.03 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 61.12 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 72.43 111.145 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 71.21 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 72.34 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.777 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 51.52 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.34 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.32 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 52.43 111.102 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.895 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.506 -0.237 . . . . 73.42 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.54 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 64.14 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 73.24 110.879 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.22 111.143 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.41 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.32 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.04 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.139 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.881 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 64.05 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 72.21 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.12 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 61.22 110.846 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 74.34 111.144 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.04 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 74.32 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.776 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.22 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.096 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.906 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.49 -0.244 . . . . 50.32 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.45 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.674 ' HA ' HG22 ' A' ' 8' ' ' ILE . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.874 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.03 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 55.14 111.152 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.41 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.13 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 64.04 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 54.34 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 51.01 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 72.32 111.146 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 73.01 110.905 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 53.12 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 65.42 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.496 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.852 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.23 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 71.55 111.129 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.23 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 51.1 111.161 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.22 110.919 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.504 -0.238 . . . . 61.34 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 72.32 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.11 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.1 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.04 111.085 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 34.02 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.04 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.14 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 54.04 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 72.14 111.112 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 64.41 110.895 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.467 -0.253 . . . . 63.22 112.467 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 73.24 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.12 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.677 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.861 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.34 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.33 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.42 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 62.11 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.44 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 63.22 111.155 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.958 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.856 0.36 . . . . 75.31 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.29 18.26 10.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 44.32 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.23 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 64.12 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.43 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.14 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.24 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.3 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 52.34 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 64.3 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 74.05 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.709 ' CZ2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.0 110.943 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.33 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.41 111.111 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -89.93 -54.12 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.938 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 12' ' ' TRP . 2.5 tm? -130.18 116.78 18.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 70.02 110.91 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 16' ' ' LEU . . . 105.87 -10.25 44.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 52.44 112.462 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 41.8 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 73.41 110.885 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.831 0.348 . . . . 64.31 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.19 18.17 11.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 60.22 112.479 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 61.15 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.11 110.867 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.13 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.05 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 71.21 111.152 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.12 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.01 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 63.41 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 70.45 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.33 111.148 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -88.88 -54.61 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 63.51 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -128.26 119.33 24.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 60.33 110.908 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.08 57.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 71.04 112.449 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 70.53 110.91 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.797 0.332 . . . . 74.3 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.12 18.27 54.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 70.14 112.503 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 71.43 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.31 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.22 110.85 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.14 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.14 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 54.33 111.13 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.31 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 53.33 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.52 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.51 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 64.25 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -88.98 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 62.45 110.922 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.26 119.32 24.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.899 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.2 57.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 50.44 112.457 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.7 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 75.34 110.884 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.874 0.369 . . . . 73.43 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.28 16.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 34.1 112.49 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 65.5 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 71.32 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.3 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.43 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 53.22 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 53.23 111.137 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.54 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.1 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.14 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.01 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.05 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 54.13 111.108 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -89.01 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.22 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.31 119.31 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 73.23 110.934 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.0 57.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 70.22 112.485 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 61.42 110.857 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.845 0.355 . . . . 70.34 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.36 18.24 19.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 55.5 112.531 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 72.43 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.43 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' A' ' 8' ' ' ILE . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.11 110.834 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 63.13 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.55 111.173 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.54 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.41 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.3 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.21 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.2 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 61.41 111.096 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -88.96 -54.55 4.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.23 110.914 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.26 119.34 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 62.42 110.937 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -7.08 57.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 3.21 112.499 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 65.34 110.908 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.842 0.353 . . . . 72.32 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.1 18.24 29.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 62.14 112.501 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 73.52 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 62.15 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.43 110.881 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.21 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.12 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.32 111.093 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.21 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 72.44 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.31 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.52 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.13 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.2 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -88.93 -54.56 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.954 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 tp -128.25 119.33 24.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 42.51 110.944 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -6.97 57.36 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 72.04 112.483 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.3 p90 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 65.43 110.884 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.85 0.357 . . . . 70.05 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 18.24 33.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 73.53 112.491 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 74.14 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.34 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 8' ' ' ILE . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.03 110.879 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.4 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.04 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 73.41 111.154 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 62.24 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 70.04 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.41 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 65.45 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.13 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.03 111.121 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -88.97 -54.54 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -128.28 119.32 24.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 64.31 110.878 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.26 57.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 73.41 112.484 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 71.31 110.851 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.872 0.368 . . . . 64.23 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.12 17.99 9.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 73.44 112.491 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 71.03 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 62.35 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.12 110.874 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 54.22 111.147 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 71.3 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 72.41 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.12 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 71.04 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.13 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 53.55 111.109 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -89.1 -54.53 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.43 110.849 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.29 119.3 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 73.21 110.944 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.11 57.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 53.2 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 64.43 110.91 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.352 . . . . 71.1 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.74 17.78 72.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 44.12 112.443 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 65.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.02 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.43 110.92 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.13 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 44.04 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.02 111.091 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.03 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 74.44 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.14 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 72.12 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.44 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -89.04 -54.53 4.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.2 110.938 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.29 119.26 24.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 74.3 110.9 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.99 -7.18 57.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 54.33 112.511 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 62.12 110.867 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.858 0.361 . . . . 64.54 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.15 59.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 64.15 112.516 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 65.3 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.41 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 40.21 110.924 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.23 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 63.24 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 64.54 111.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 61.34 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.24 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 54.14 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.43 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 61.4 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.23 111.149 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -88.95 -54.5 4.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.44 110.982 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.34 119.3 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 65.4 110.877 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.1 57.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 50.33 112.448 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 72.03 110.873 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.846 0.355 . . . . 75.11 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.56 18.17 21.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 55.12 112.518 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 55.22 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.21 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.44 110.866 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.3 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.4 111.12 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.05 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.01 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 74.13 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.54 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.24 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 71.42 111.132 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -89.03 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.12 110.913 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 tp -128.27 119.3 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.781 -0.723 . . . . 62.51 112.512 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.6 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 72.52 110.872 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.899 0.38 . . . . 74.12 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.21 56.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 61.01 112.526 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 62.1 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.33 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 61.21 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.21 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 70.54 111.108 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.54 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 72.34 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 64.11 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.11 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.42 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.11 111.182 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -89.05 -54.55 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 71.44 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.27 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 72.03 110.938 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.08 57.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 44.22 112.491 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 63.42 110.889 -179.875 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.855 0.36 . . . . 64.42 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.91 18.23 79.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 73.33 112.484 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.41 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.02 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 62.14 110.88 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.41 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 55.51 111.139 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 65.45 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.51 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 71.34 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 63.31 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 32.11 111.151 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -89.02 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 72.44 110.936 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.26 119.33 24.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 71.04 110.92 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 72.22 112.478 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 74.14 110.855 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.877 0.37 . . . . 73.42 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.76 18.2 38.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 73.43 112.513 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.23 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.681 ' HA ' HG22 ' A' ' 8' ' ' ILE . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.22 110.882 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 63.03 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 61.12 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 72.43 111.145 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 71.21 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 72.34 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.777 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 51.52 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.34 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.32 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 52.43 111.102 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -88.99 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.33 110.895 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.3 119.24 24.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 61.45 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.97 -7.19 57.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 64.22 112.486 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 64.53 110.883 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.855 0.359 . . . . 63.45 110.916 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.63 18.19 16.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 73.42 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.54 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 64.14 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 73.24 110.879 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.43 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.22 111.143 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.24 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.41 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.32 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.12 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.04 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.139 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.0 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.45 110.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.29 119.28 24.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.2 110.92 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.91 -7.13 57.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 74.11 112.464 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.6 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.774 0.321 . . . . 73.51 110.841 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 65.01 110.914 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.24 18.3 26.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 64.05 112.499 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 72.21 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.12 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 61.22 110.846 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.31 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.14 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 74.34 111.144 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.04 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 74.32 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.776 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.22 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 61.53 111.096 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -89.03 -54.54 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 71.32 110.906 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.26 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 60.1 110.929 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.99 57.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 71.55 112.483 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 64.02 110.844 -179.863 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.855 0.36 . . . . 61.21 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.28 77.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 50.32 112.49 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.45 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.14 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.674 ' HA ' HG22 ' A' ' 8' ' ' ILE . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.34 110.874 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.03 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 55.14 111.152 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.41 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.13 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 64.04 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 54.34 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 51.01 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 72.32 111.146 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -88.98 -54.59 4.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 73.01 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 17' ' ' GLY . 8.4 tp -128.25 119.29 24.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.04 110.944 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 16' ' ' LEU . . . 100.9 -7.1 57.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 72.41 112.483 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.8 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 74.15 110.848 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.856 0.36 . . . . 73.34 110.899 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.03 18.22 70.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.738 . . . . 53.12 112.501 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 65.42 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.496 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.51 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.4 110.852 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.23 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.24 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 71.55 111.129 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.23 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.15 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 51.1 111.161 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -88.98 -54.56 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.22 110.919 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -128.28 119.31 24.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 71.31 110.926 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.1 57.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.739 . . . . 74.3 112.519 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 72.53 110.924 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.881 0.372 . . . . 75.13 110.919 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.11 18.21 56.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 61.34 112.504 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 72.32 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.11 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.1 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.04 111.085 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 34.02 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.04 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.14 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.41 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 54.04 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 72.14 111.112 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -89.02 -54.56 4.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 64.41 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -128.28 119.34 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 71.02 110.95 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.83 -7.08 57.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 34.22 112.499 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 63.35 110.909 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.863 0.363 . . . . 70.11 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.43 18.21 13.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 63.22 112.467 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 73.24 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.12 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.677 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.52 110.861 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.33 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.34 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.33 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.41 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.42 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 62.11 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HA ' ' HE3' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.44 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 63.22 111.155 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -88.92 -54.57 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.958 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.4 tp -128.24 119.35 25.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.04 110.9 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.09 57.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 50.12 112.496 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 71.22 110.872 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 N-CA-C 112.5 -0.24 . . . . 44.32 112.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.230000000000004 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 64.120000000000005 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.430000000000007 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.140000000000001 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.299999999999997 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 52.340000000000003 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 64.299999999999997 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 74.049999999999997 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.0 110.943 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.329999999999998 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.111 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.938 179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.479 -0.249 . . . . 60.219999999999999 112.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 61.149999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.867 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.049999999999997 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 111.152 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.120000000000005 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.010000000000005 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 63.409999999999997 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 70.450000000000003 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.329999999999998 111.148 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 63.509999999999998 110.926 179.942 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.503 -0.239 . . . . 70.140000000000001 112.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 71.430000000000007 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.85 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 54.329999999999998 111.13 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.239999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.310000000000002 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 53.329999999999998 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 64.25 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 62.450000000000003 110.922 179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.49 -0.244 . . . . 34.100000000000001 112.49 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 65.5 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 71.319999999999993 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 53.219999999999999 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 53.229999999999997 111.137 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.540000000000006 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.099999999999994 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.140000000000001 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.010000000000005 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 54.130000000000003 111.108 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.219999999999999 110.912 179.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.531 -0.228 . . . . 55.5 112.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' A' ' 8' ' ' ILE . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.834 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 63.130000000000003 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 111.173 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.299999999999997 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 61.409999999999997 111.096 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.914 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.501 -0.24 . . . . 62.140000000000001 112.501 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 73.519999999999996 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 62.149999999999999 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.430000000000007 110.881 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.093 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 72.439999999999998 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.519999999999996 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.954 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.491 -0.243 . . . . 73.530000000000001 112.491 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 74.140000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 8' ' ' ILE . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.030000000000001 110.879 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.154 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 62.240000000000002 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 70.040000000000006 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.409999999999997 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 65.450000000000003 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.129999999999995 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.030000000000001 111.121 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.939 179.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 N-CA-C 112.491 -0.244 . . . . 73.439999999999998 112.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 71.030000000000001 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 62.350000000000001 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.874 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 54.219999999999999 111.147 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 72.409999999999997 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.120000000000005 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 71.040000000000006 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 53.549999999999997 111.109 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.849 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.326 0 N-CA-C 112.443 -0.263 . . . . 44.119999999999997 112.443 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 65.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.92 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 44.039999999999999 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 111.091 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.030000000000001 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 74.439999999999998 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.140000000000001 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.200000000000003 110.938 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 N-CA-C 112.516 -0.234 . . . . 64.150000000000006 112.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 65.299999999999997 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 40.210000000000001 110.924 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 63.240000000000002 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 64.540000000000006 111.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.239999999999995 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 54.140000000000001 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 61.399999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.149 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.982 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.518 -0.233 . . . . 55.119999999999997 112.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 55.219999999999999 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.439999999999998 110.866 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.299999999999997 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 111.12 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.049999999999997 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.010000000000005 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 74.129999999999995 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.239999999999995 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 71.420000000000002 111.132 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.120000000000005 110.913 -179.995 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.526 -0.23 . . . . 61.009999999999998 112.526 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 62.100000000000001 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.329999999999998 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 70.540000000000006 111.108 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.539999999999999 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 72.340000000000003 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 64.109999999999999 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.109999999999999 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 111.182 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 71.439999999999998 110.92 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.484 -0.247 . . . . 73.329999999999998 112.484 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.409999999999997 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.019999999999996 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 62.140000000000001 110.88 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 55.509999999999998 111.139 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 65.450000000000003 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.510000000000005 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 71.340000000000003 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 70.310000000000002 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 32.109999999999999 111.151 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 110.936 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.513 -0.235 . . . . 73.430000000000007 112.513 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.230000000000004 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.681 ' HA ' HG22 ' A' ' 8' ' ' ILE . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.882 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 63.030000000000001 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 61.119999999999997 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 111.145 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 71.209999999999994 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 72.340000000000003 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.777 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 51.520000000000003 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.340000000000003 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.319999999999993 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 52.43 111.102 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.379 0 N-CA-C 112.506 -0.237 . . . . 73.420000000000002 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 64.140000000000001 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 73.239999999999995 110.879 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 111.143 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.409999999999997 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.319999999999993 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.040000000000006 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.139 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 110.881 179.993 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.499 -0.24 . . . . 64.049999999999997 112.499 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.119999999999997 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 61.219999999999999 110.846 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 74.340000000000003 111.144 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.040000000000006 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 74.319999999999993 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.776 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 61.530000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 110.906 179.982 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.49 -0.244 . . . . 50.32 112.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.450000000000003 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.140000000000001 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.674 ' HA ' HG22 ' A' ' 8' ' ' ILE . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.874 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.030000000000001 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 55.140000000000001 111.152 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.129999999999995 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 64.040000000000006 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 54.340000000000003 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 51.009999999999998 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.146 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.905 179.978 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.501 -0.239 . . . . 53.119999999999997 112.501 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 65.420000000000002 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.496 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.510000000000005 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.852 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.239999999999995 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 71.549999999999997 111.129 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 51.100000000000001 111.161 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.219999999999999 110.919 179.968 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.385 0 N-CA-C 112.504 -0.238 . . . . 61.340000000000003 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 72.319999999999993 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.109999999999999 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.040000000000006 111.085 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 34.020000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.040000000000006 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.140000000000001 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 54.039999999999999 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 72.140000000000001 111.112 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 . . . . . 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 64.409999999999997 110.895 179.983 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.467 -0.253 . . . . 63.219999999999999 112.467 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 73.239999999999995 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TYR . . . . . 0.499 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.120000000000005 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.677 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.861 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.420000000000002 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 62.109999999999999 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 63.219999999999999 111.155 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.958 179.955 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.8 mt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.856 0.36 . . . . 75.310000000000002 110.874 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.29 18.26 10.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 44.32 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.01 -37.23 12.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 74.230000000000004 110.906 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.524 ' O ' HG22 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -72.47 -55.68 6.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.229 -0.442 . . . . 64.120000000000005 110.89 -179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 16.4 mt-10 -60.15 -7.35 1.82 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.501 . . . . 74.430000000000007 110.912 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -93.64 -35.8 12.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 71.140000000000001 110.968 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.4 OUTLIER -99.87 -22.13 15.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.153 -0.476 . . . . 73.239999999999995 110.956 -179.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 0.4 OUTLIER -87.19 -12.82 10.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.072 -0.513 . . . . 70.299999999999997 111.124 179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 12.1 pttp -73.93 -7.77 53.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 52.340000000000003 110.932 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.5 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 40.9 m95 -73.95 -59.47 1.79 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.561 0.696 . . . . 64.299999999999997 110.933 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.77 -29.12 24.31 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.656 2.238 . . . . 74.049999999999997 112.317 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.709 ' CZ2' HD12 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -74.0 -20.17 60.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.236 -0.438 . . . . 73.0 110.943 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.6 m-30 -68.98 -45.05 71.6 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.252 -0.431 . . . . 72.329999999999998 110.898 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 14.3 m -40.4 -32.9 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 74.409999999999997 111.111 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 5.7 t-105 -89.93 -54.12 4.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.217 -0.447 . . . . 54.32 110.938 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.709 HD12 ' CZ2' ' A' ' 12' ' ' TRP . 2.5 tm? -130.18 116.78 18.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 70.019999999999996 110.91 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.4 ' N ' HD22 ' A' ' 16' ' ' LEU . . . 105.87 -10.25 44.51 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 52.439999999999998 112.462 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 41.8 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.796 0.331 . . . . 73.409999999999997 110.885 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.831 0.348 . . . . 64.310000000000002 110.919 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 106.19 18.17 11.64 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.733 -0.746 . . . . 60.219999999999999 112.479 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.7 -37.06 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.824 0.345 . . . . 61.149999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.14 11.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.923 -179.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.9 mt-10 -61.5 -7.51 3.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 110.867 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -93.91 -36.0 12.41 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 74.129999999999995 110.936 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.87 15.74 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.235 -0.439 . . . . 72.049999999999997 110.925 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.676 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.26 9.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.145 -0.48 . . . . 71.209999999999994 111.152 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 74.120000000000005 110.879 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.75 -58.14 5.85 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.55 0.69 . . . . 72.010000000000005 110.906 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.71 4.0 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.667 2.245 . . . . 63.409999999999997 112.347 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.71 18.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 70.450000000000003 110.933 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.14 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.934 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 62.329999999999998 111.148 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -88.88 -54.61 4.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 63.509999999999998 110.926 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.471 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -128.26 119.33 24.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 60.329999999999998 110.908 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.86 -7.08 57.23 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.737 -0.744 . . . . 71.040000000000006 112.449 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.782 0.325 . . . . 70.530000000000001 110.91 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.797 0.332 . . . . 74.299999999999997 110.893 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.12 18.27 54.06 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.785 -0.722 . . . . 70.140000000000001 112.503 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.45 -37.09 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 71.430000000000007 110.911 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.92 -53.1 12.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 110.934 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 76.8 mt-10 -61.54 -7.47 3.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 72.219999999999999 110.85 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -93.97 -36.01 12.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 71.140000000000001 110.91 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.518 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.76 15.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 74.140000000000001 110.948 -179.899 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 54.329999999999998 111.13 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.82 -6.95 55.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 71.239999999999995 110.89 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.79 -58.16 5.78 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.57 0.7 . . . . 74.310000000000002 110.894 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.785 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.3 Cg_endo -69.7 -41.73 4.08 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.701 2.267 . . . . 53.329999999999998 112.376 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.67 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 72.519999999999996 110.942 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.15 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 110.917 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.785 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.3 m -41.26 -34.31 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.505 . . . . 64.25 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 31.4 t-105 -88.98 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 62.450000000000003 110.922 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.26 119.32 24.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.899 179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.92 -7.2 57.18 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.74 . . . . 50.439999999999998 112.457 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.41 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.7 p90 . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.821 0.344 . . . . 75.340000000000003 110.884 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.874 0.369 . . . . 73.430000000000007 110.944 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.82 18.28 16.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 34.100000000000001 112.49 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.57 -36.87 10.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.724 0.297 . . . . 65.5 110.85 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.07 12.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.262 -0.427 . . . . 71.319999999999993 110.966 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mm-40 -61.65 -7.36 3.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 64.299999999999997 110.868 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.02 -35.97 12.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.156 -0.475 . . . . 73.430000000000007 110.887 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.8 15.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 53.219999999999999 110.94 -179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.55 -15.34 9.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 53.229999999999997 111.137 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.78 -7.02 55.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 73.540000000000006 110.884 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.73 -58.16 5.86 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.581 0.705 . . . . 73.099999999999994 110.905 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.78 -41.66 4.05 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.694 2.263 . . . . 75.140000000000001 112.34 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.52 -32.77 19.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 75.010000000000005 110.909 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.217 -0.447 . . . . 71.049999999999997 110.909 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.17 -34.41 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.124 -0.489 . . . . 54.130000000000003 111.108 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -89.01 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.148 -0.478 . . . . 75.219999999999999 110.912 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.31 119.31 24.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.275 -0.421 . . . . 73.230000000000004 110.934 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.0 57.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.757 -0.735 . . . . 70.219999999999999 112.485 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 61.420000000000002 110.857 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.845 0.355 . . . . 70.340000000000003 110.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.36 18.24 19.69 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 55.5 112.531 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.58 -36.99 10.55 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.764 0.316 . . . . 72.430000000000007 110.923 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -53.2 11.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 74.430000000000007 110.895 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' A' ' 8' ' ' ILE . 65.0 mm-40 -61.51 -7.49 3.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 73.109999999999999 110.834 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -93.91 -35.95 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 63.130000000000003 110.951 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.509 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.2 -20.96 15.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 73.25 110.906 -179.894 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.667 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.22 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 111.173 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -77.74 -6.97 55.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.174 -0.466 . . . . 72.540000000000006 110.952 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.3 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.576 0.703 . . . . 75.409999999999997 110.883 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.774 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.79 -41.64 4.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.69 2.26 . . . . 65.299999999999997 112.369 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.54 -32.74 19.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.909 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.11 -57.47 2.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 110.908 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.19 -34.43 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.108 -0.496 . . . . 61.409999999999997 111.096 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.3 t-105 -88.96 -54.55 4.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 75.230000000000004 110.914 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.2 tp -128.26 119.34 24.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.281 -0.418 . . . . 62.420000000000002 110.937 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.85 -7.08 57.23 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.728 -0.749 . . . . 3.21 112.499 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 65.340000000000003 110.908 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.6 tp . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.842 0.353 . . . . 72.319999999999993 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 97.1 18.24 29.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.758 -0.734 . . . . 62.140000000000001 112.501 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.36 -36.95 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.797 0.332 . . . . 73.519999999999996 110.868 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -53.02 12.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 62.149999999999999 110.916 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 38.2 mt-10 -61.59 -7.43 3.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 75.430000000000007 110.881 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -93.98 -36.05 12.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 61.210000000000001 110.93 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.61 15.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 110.909 -179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.46 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 74.319999999999993 111.093 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -7.0 55.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 73.209999999999994 110.869 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.74 -58.13 5.88 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.551 0.691 . . . . 72.439999999999998 110.945 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.4 Cg_endo -69.79 -41.73 3.99 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.69 2.26 . . . . 71.310000000000002 112.274 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.44 -32.71 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 70.519999999999996 110.958 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.19 -57.41 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 75.129999999999995 110.97 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.23 -34.39 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 74.200000000000003 111.131 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 49.1 t-105 -88.93 -54.56 4.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.169 -0.469 . . . . 73.25 110.954 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 tp -128.25 119.33 24.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 42.509999999999998 110.944 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -6.97 57.36 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.721 -0.752 . . . . 72.040000000000006 112.483 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.3 p90 . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.785 0.326 . . . . 65.430000000000007 110.884 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 15.8 tp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.85 0.357 . . . . 70.049999999999997 110.894 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.48 18.24 33.73 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.752 -0.737 . . . . 73.530000000000001 112.491 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -92.73 -37.06 12.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.816 0.341 . . . . 74.140000000000001 110.919 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.493 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.94 12.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 75.340000000000003 110.938 -179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 8' ' ' ILE . 14.5 mm-40 -61.62 -7.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 70.030000000000001 110.879 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.08 -35.96 12.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.466 . . . . 54.399999999999999 110.925 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.516 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.26 -20.65 15.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.224 -0.444 . . . . 74.040000000000006 110.901 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.669 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.39 9.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 111.154 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.4 ptmm? -77.8 -6.93 55.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 62.240000000000002 110.868 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.533 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.86 -58.16 5.71 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-O 121.593 0.711 . . . . 70.040000000000006 110.943 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.78 -41.67 4.05 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.409999999999997 112.325 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.47 -32.7 18.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.43 . . . . 65.450000000000003 110.931 179.924 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.18 -57.47 2.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.284 -0.416 . . . . 71.129999999999995 110.912 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.19 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.087 -0.506 . . . . 73.030000000000001 111.121 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 18.8 t90 -88.97 -54.54 4.08 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.197 -0.456 . . . . 72.0 110.939 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -128.28 119.32 24.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 64.310000000000002 110.878 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.94 -7.26 57.18 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.738 -0.744 . . . . 73.409999999999997 112.484 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.774 0.321 . . . . 71.310000000000002 110.851 -179.812 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.872 0.368 . . . . 64.230000000000004 110.917 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.12 17.99 9.65 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.693 -0.765 . . . . 73.439999999999998 112.491 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.06 -36.94 10.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.768 0.318 . . . . 71.030000000000001 110.856 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.94 -52.84 13.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.436 . . . . 62.350000000000001 110.891 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 8.2 mt-10 -61.78 -7.36 3.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 73.120000000000005 110.874 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -94.11 -35.97 12.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.914 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.29 -20.37 15.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.9 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.54 -15.49 9.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 54.219999999999999 111.147 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? -77.8 -7.07 56.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 71.299999999999997 110.86 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.68 -58.19 5.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.626 0.727 . . . . 72.409999999999997 110.942 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.9 Cg_endo -69.76 -41.72 4.03 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.623 2.216 . . . . 73.120000000000005 112.37 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.78 18.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.255 -0.43 . . . . 71.040000000000006 110.889 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.426 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.21 -57.47 2.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 75.129999999999995 110.883 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.19 -34.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 53.549999999999997 111.109 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -89.1 -54.53 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 74.430000000000007 110.849 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.494 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.29 119.3 24.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.291 -0.413 . . . . 73.209999999999994 110.944 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.11 57.2 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.755 -0.736 . . . . 53.200000000000003 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.822 0.344 . . . . 64.430000000000007 110.91 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.4 tt . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.838 0.352 . . . . 71.099999999999994 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.74 17.78 72.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.773 -0.727 . . . . 44.119999999999997 112.443 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.34 -36.98 12.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.76 0.314 . . . . 65.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.03 -52.77 13.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 72.019999999999996 110.911 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 17.0 mm-40 -61.72 -7.33 3.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 64.430000000000007 110.92 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -36.08 12.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 74.129999999999995 110.884 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.27 -20.14 16.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 44.039999999999999 110.946 -179.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.62 -15.56 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 71.019999999999996 111.091 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 3.5 ptmm? -77.76 -6.97 55.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 74.030000000000001 110.855 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.7 m95 -69.78 -58.19 5.76 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.592 0.71 . . . . 74.439999999999998 110.899 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.77 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.77 -41.59 4.13 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.652 2.235 . . . . 73.140000000000001 112.367 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.48 -32.77 19.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.953 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.17 -57.4 2.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.21 -0.45 . . . . 74.439999999999998 110.944 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.2 m -41.2 -34.33 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 75.25 111.139 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -89.04 -54.53 4.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 72.200000000000003 110.938 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.536 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.29 119.26 24.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 74.299999999999997 110.9 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.99 -7.18 57.06 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.73 -0.747 . . . . 54.329999999999998 112.511 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.774 0.321 . . . . 62.119999999999997 110.867 -179.865 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.858 0.361 . . . . 64.540000000000006 110.907 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.29 18.15 59.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.693 -0.765 . . . . 64.150000000000006 112.516 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.1 mmtm -96.71 -37.05 10.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 65.299999999999997 110.9 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.506 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.98 -52.52 14.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.89 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.68 ' HA ' HG22 ' A' ' 8' ' ' ILE . 4.8 pt-20 -61.88 -7.3 3.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 40.210000000000001 110.924 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.24 -36.08 12.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 75.230000000000004 110.927 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.33 -19.83 16.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 63.240000000000002 110.912 -179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.68 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.63 -15.67 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 64.540000000000006 111.121 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.77 -6.89 55.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.173 -0.467 . . . . 61.340000000000003 110.925 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.86 -58.13 5.73 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.566 0.698 . . . . 64.239999999999995 110.919 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.6 Cg_endo -69.79 -41.73 3.98 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.709 2.272 . . . . 54.140000000000001 112.295 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.8 18.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 110.933 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.15 -57.45 2.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 61.399999999999999 110.91 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.17 -34.4 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 74.230000000000004 111.149 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -88.95 -54.5 4.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 75.439999999999998 110.982 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.562 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.34 119.3 24.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 65.400000000000006 110.877 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.1 57.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.737 -0.744 . . . . 50.329999999999998 112.448 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.791 0.329 . . . . 72.030000000000001 110.873 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.846 0.355 . . . . 75.109999999999999 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.56 18.17 21.78 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.731 -0.747 . . . . 55.119999999999997 112.518 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 -37.07 12.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.33 . . . . 55.219999999999999 110.885 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.42 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.903 -179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.673 ' HA ' HG22 ' A' ' 8' ' ' ILE . 3.5 pt-20 -61.92 -7.34 3.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 75.439999999999998 110.866 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -94.31 -36.07 12.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 110.887 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.35 -19.69 16.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.265 -0.425 . . . . 74.299999999999997 110.91 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.673 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.72 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 72.400000000000006 111.12 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -6.98 55.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.049999999999997 110.897 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.78 -58.16 5.8 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.577 0.703 . . . . 74.010000000000005 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.74 -41.72 4.05 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.729 2.286 . . . . 74.129999999999995 112.342 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.524 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.39 -32.87 18.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.188 -0.46 . . . . 75.540000000000006 110.886 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.39 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.286 -0.416 . . . . 72.239999999999995 110.931 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.16 -34.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.505 . . . . 71.420000000000002 111.132 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -89.03 -54.52 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.141 -0.481 . . . . 73.120000000000005 110.913 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.9 tp -128.27 119.3 24.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.0 110.888 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.21 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.781 -0.723 . . . . 62.509999999999998 112.512 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.6 p90 . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 72.519999999999996 110.872 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.899 0.38 . . . . 74.120000000000005 110.913 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.08 18.21 56.26 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.751 . . . . 61.009999999999998 112.526 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -94.93 -36.94 11.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.812 0.339 . . . . 62.100000000000001 110.906 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.501 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.08 -52.39 14.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.921 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' HA ' HG22 ' A' ' 8' ' ' ILE . 12.6 mt-10 -61.88 -7.36 3.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.09 -0.505 . . . . 62.329999999999998 110.913 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.26 -36.08 12.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 61.210000000000001 110.87 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.506 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.37 -19.78 16.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 74.209999999999994 110.887 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.672 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 70.540000000000006 111.108 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.76 -6.97 55.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.244 -0.435 . . . . 63.539999999999999 110.902 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.9 m95 -69.77 -58.17 5.79 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 72.340000000000003 110.951 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.779 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.77 -41.7 4.04 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.676 2.251 . . . . 64.109999999999999 112.344 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.525 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.36 -32.81 18.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 74.109999999999999 110.907 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.22 -57.45 2.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 72.420000000000002 110.874 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.779 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.15 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 111.182 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.7 t-105 -89.05 -54.55 4.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.469 . . . . 71.439999999999998 110.92 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.3 tp -128.27 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.938 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.89 -7.08 57.17 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.752 -0.737 . . . . 44.219999999999999 112.491 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.5 p90 . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.793 0.33 . . . . 63.420000000000002 110.889 -179.875 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.855 0.36 . . . . 64.420000000000002 110.921 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.91 18.23 79.65 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 73.329999999999998 112.484 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.05 -37.01 10.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.785 0.326 . . . . 72.409999999999997 110.897 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.502 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.95 -52.44 14.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 75.019999999999996 110.921 179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 9.7 mm-40 -61.95 -7.32 3.65 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 62.140000000000001 110.88 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.27 -36.05 12.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.143 -0.481 . . . . 74.409999999999997 110.896 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.502 ' CD2' ' HA ' ' A' ' 4' ' ' TYR . 0.5 OUTLIER -100.34 -19.77 16.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.87 -179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.65 -15.63 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 55.509999999999998 111.139 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.73 -7.04 55.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.175 -0.466 . . . . 65.450000000000003 110.872 179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.536 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.14 5.78 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.565 0.698 . . . . 75.510000000000005 110.911 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.78 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.8 Cg_endo -69.72 -41.76 4.04 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.299 . . . . 71.340000000000003 112.329 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.521 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.82 18.52 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 63.310000000000002 110.95 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.16 -57.49 2.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.196 -0.456 . . . . 70.310000000000002 110.911 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 11' ' ' PRO . 18.9 m -41.14 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 32.109999999999999 111.151 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 52.3 t-105 -89.02 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.179 -0.464 . . . . 72.439999999999998 110.936 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.518 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.26 119.33 24.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 71.040000000000006 110.92 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -7.1 57.2 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 72.219999999999999 112.478 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.812 0.339 . . . . 74.140000000000001 110.855 -179.844 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 tt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.877 0.37 . . . . 73.420000000000002 110.9 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.76 18.2 38.64 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 73.430000000000007 112.513 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.94 -37.01 13.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.786 0.327 . . . . 71.230000000000004 110.881 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.97 -52.33 14.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.933 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.681 ' HA ' HG22 ' A' ' 8' ' ' ILE . 72.7 mm-40 -61.9 -7.43 3.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 72.219999999999999 110.882 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.2 mt-30 -94.22 -36.13 12.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 63.030000000000001 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.36 -19.64 16.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 61.119999999999997 110.928 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.681 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 72.430000000000007 111.145 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.3 ptpp? -77.74 -6.97 55.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.463 . . . . 71.209999999999994 110.942 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.8 -58.2 5.74 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.586 0.708 . . . . 72.340000000000003 110.86 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.777 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.0 Cg_endo -69.72 -41.73 4.07 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.675 2.25 . . . . 51.520000000000003 112.375 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.53 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.38 -32.81 18.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 72.340000000000003 110.946 179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.2 -57.44 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 74.319999999999993 110.9 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.777 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.18 -34.34 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 52.43 111.102 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 17.3 t90 -88.99 -54.58 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 110.895 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -128.3 119.24 24.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 61.450000000000003 110.877 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.97 -7.19 57.1 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.711 -0.757 . . . . 64.219999999999999 112.486 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.836 0.35 . . . . 64.530000000000001 110.883 -179.863 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.855 0.359 . . . . 63.450000000000003 110.916 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 102.63 18.19 16.89 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.754 -0.736 . . . . 73.420000000000002 112.506 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -91.8 -37.01 13.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.828 0.347 . . . . 74.540000000000006 110.913 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.495 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.99 -52.24 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 64.140000000000001 110.913 -179.96 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 22.4 mt-10 -62.03 -7.35 3.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 73.239999999999995 110.879 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -94.26 -36.14 12.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 73.109999999999999 110.888 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.38 -19.59 16.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 73.430000000000007 110.889 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.75 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.116 -0.493 . . . . 75.219999999999999 111.143 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -77.69 -7.03 55.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.465 . . . . 73.239999999999995 110.899 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 37.0 m95 -69.73 -58.25 5.77 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.555 0.693 . . . . 74.409999999999997 110.93 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.784 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.73 -41.69 4.09 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.682 2.254 . . . . 72.319999999999993 112.328 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.4 -32.83 18.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 72.120000000000005 110.864 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.423 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.17 -57.47 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 75.040000000000006 110.894 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.784 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.18 -34.33 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 73.310000000000002 111.139 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.0 -54.57 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 72.450000000000003 110.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.569 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -128.29 119.28 24.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 61.200000000000003 110.92 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.91 -7.13 57.17 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.713 -0.756 . . . . 74.109999999999999 112.464 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.6 p90 . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.774 0.321 . . . . 73.510000000000005 110.841 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 65.010000000000005 110.914 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.24 18.3 26.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.775 -0.726 . . . . 64.049999999999997 112.499 179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.0 -37.09 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.798 0.332 . . . . 72.209999999999994 110.869 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.497 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.02 -52.24 15.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.119999999999997 110.934 -179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.679 ' HA ' HG22 ' A' ' 8' ' ' ILE . 5.1 mt-10 -61.98 -7.37 3.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 61.219999999999999 110.846 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.26 -36.12 12.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.188 -0.46 . . . . 73.310000000000002 110.92 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.507 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.39 -19.58 16.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.939 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.679 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.57 -15.76 9.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.094 -0.503 . . . . 74.340000000000003 111.144 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -77.71 -6.96 55.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.040000000000006 110.886 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.8 m95 -69.81 -58.15 5.76 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.531 0.682 . . . . 74.319999999999993 110.935 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.776 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.75 -41.68 4.08 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.666 2.244 . . . . 74.219999999999999 112.352 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.526 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.81 18.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.919 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.43 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.3 m-85 -43.18 -57.34 3.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.943 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.776 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.1 m -41.28 -34.33 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 61.530000000000001 111.096 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -89.03 -54.54 4.07 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.215 -0.448 . . . . 71.319999999999993 110.906 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.8 OUTLIER -128.26 119.26 24.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.201 -0.454 . . . . 60.100000000000001 110.929 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.88 -6.99 57.15 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.778 -0.725 . . . . 71.549999999999997 112.483 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 120.746 0.308 . . . . 64.019999999999996 110.844 -179.863 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 mt . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.855 0.36 . . . . 61.210000000000001 110.869 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.91 18.28 77.21 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 50.32 112.49 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.7 mttt -94.95 -36.84 11.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.777 0.322 . . . . 75.450000000000003 110.868 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.5 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -73.0 -53.1 12.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.263 -0.426 . . . . 71.140000000000001 110.896 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.674 ' HA ' HG22 ' A' ' 8' ' ' ILE . 24.4 mt-10 -61.57 -7.43 3.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 110.874 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -93.93 -36.03 12.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 110.896 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.21 -20.86 15.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 75.030000000000001 110.894 -179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.674 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.52 -15.31 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 55.140000000000001 111.152 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.81 -6.98 55.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 73.409999999999997 110.87 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.6 m95 -69.83 -58.14 5.76 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.557 0.694 . . . . 74.129999999999995 110.885 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.73 -41.77 4.01 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.686 2.257 . . . . 64.040000000000006 112.334 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.42 -32.77 18.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 54.340000000000003 110.931 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.2 -57.37 2.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.415 . . . . 51.009999999999998 110.935 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.0 m -41.23 -34.37 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.121 -0.49 . . . . 72.319999999999993 111.146 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 39.2 t-105 -88.98 -54.59 4.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 110.905 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 17' ' ' GLY . 8.4 tp -128.25 119.29 24.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 75.040000000000006 110.944 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.418 ' N ' HD12 ' A' ' 16' ' ' LEU . . . 100.9 -7.1 57.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 72.409999999999997 112.483 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.8 p90 . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.34 . . . . 74.150000000000006 110.848 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.856 0.36 . . . . 73.340000000000003 110.899 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.03 18.22 70.23 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.738 . . . . 53.119999999999997 112.501 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.53 -37.07 10.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.766 0.317 . . . . 65.420000000000002 110.87 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.496 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.91 -53.13 12.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 75.510000000000005 110.906 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.0 mm-40 -61.57 -7.4 3.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.479 . . . . 74.400000000000006 110.852 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.0 tm0? -93.92 -36.05 12.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 64.230000000000004 110.913 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.513 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.16 -20.92 15.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.211 -0.45 . . . . 71.239999999999995 110.896 -179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.663 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.58 -15.19 9.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.117 -0.492 . . . . 71.549999999999997 111.129 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.8 -7.01 56.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.892 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.537 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.81 -58.11 5.81 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.562 0.696 . . . . 74.25 110.933 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.773 ' O ' HG22 ' A' ' 14' ' ' VAL . 54.1 Cg_endo -69.71 -41.76 4.05 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.338 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.528 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.53 -32.64 18.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.945 179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.429 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.21 -57.43 2.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.239 -0.437 . . . . 73.150000000000006 110.934 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.773 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.2 -34.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.116 -0.493 . . . . 51.100000000000001 111.161 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -88.98 -54.56 4.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 75.219999999999999 110.919 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.474 HD23 ' O ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -128.28 119.31 24.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 71.310000000000002 110.926 179.969 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.87 -7.1 57.22 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.749 -0.739 . . . . 74.299999999999997 112.519 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.8 p90 . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.795 0.331 . . . . 72.530000000000001 110.924 -179.918 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.881 0.372 . . . . 75.129999999999995 110.919 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.11 18.21 56.2 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.784 -0.722 . . . . 61.340000000000003 112.504 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -37.05 10.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.78 0.324 . . . . 72.319999999999993 110.903 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.498 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.87 -53.2 12.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.46 . . . . 60.109999999999999 110.93 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.668 ' HA ' HG22 ' A' ' 8' ' ' ILE . 13.3 mt-10 -61.57 -7.38 3.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.111 -0.495 . . . . 71.0 110.902 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -93.93 -36.06 12.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.492 . . . . 72.0 110.92 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.19 -20.86 15.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 72.099999999999994 110.931 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.59 -15.19 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.096 -0.502 . . . . 74.040000000000006 111.085 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.82 -6.97 55.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 34.020000000000003 110.918 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.535 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.4 m95 -69.84 -58.1 5.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.549 0.69 . . . . 74.040000000000006 110.917 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.5 Cg_endo -69.72 -41.75 4.05 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.713 2.275 . . . . 72.140000000000001 112.331 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.529 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.55 -32.69 19.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 75.409999999999997 110.882 -179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.431 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.44 2.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.274 -0.421 . . . . 54.039999999999999 110.921 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.24 -34.34 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 72.140000000000001 111.112 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 19.4 t90 -89.02 -54.56 4.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.161 -0.472 . . . . 64.409999999999997 110.895 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.401 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.4 OUTLIER -128.28 119.34 24.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 71.019999999999996 110.95 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.83 -7.08 57.28 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.726 -0.749 . . . . 34.219999999999999 112.499 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.6 p90 . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.825 0.345 . . . . 63.350000000000001 110.909 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.863 0.363 . . . . 70.109999999999999 110.903 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 104.43 18.21 13.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.738 . . . . 63.219999999999999 112.467 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -97.09 -36.95 10.32 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.786 0.326 . . . . 73.239999999999995 110.902 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TYR . . . . . 0.499 ' HA ' ' CD2' ' A' ' 7' ' ' TYR . 0.1 OUTLIER -72.96 -53.24 11.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 64.120000000000005 110.895 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.677 ' HA ' HG22 ' A' ' 8' ' ' ILE . 2.6 mt-10 -61.54 -7.36 3.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.519999999999996 110.861 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 4.1 tm0? -93.91 -36.05 12.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.329999999999998 110.923 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.514 ' CD1' ' C ' ' A' ' 7' ' ' TYR . 0.5 OUTLIER -100.22 -20.84 15.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.902 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.677 HG22 ' HA ' ' A' ' 5' ' ' GLU . 1.1 tp -87.66 -15.13 9.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 111.132 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.85 -6.95 55.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 73.409999999999997 110.894 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.534 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 36.5 m95 -69.8 -58.13 5.8 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.548 0.69 . . . . 74.420000000000002 110.896 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.782 ' O ' HG22 ' A' ' 14' ' ' VAL . 53.7 Cg_endo -69.77 -41.71 4.03 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.681 2.254 . . . . 62.109999999999999 112.36 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . 0.531 ' HE3' ' HA ' ' A' ' 12' ' ' TRP . 0.1 OUTLIER -50.56 -32.65 19.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.935 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 10' ' ' TRP . 1.2 m-85 -43.13 -57.49 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 74.439999999999998 110.918 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 11' ' ' PRO . 19.4 m -41.15 -34.44 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.105 -0.498 . . . . 63.219999999999999 111.155 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -88.92 -54.57 4.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.958 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.4 tp -128.24 119.35 25.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 73.040000000000006 110.9 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.84 -7.09 57.27 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.725 -0.75 . . . . 50.119999999999997 112.496 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' A' ' 14' ' ' VAL . 33.5 p90 . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 120.796 0.331 . . . . 71.219999999999999 110.872 -179.835 . . . . . . . . 1 1 . 1 stop_ save_